This strategic move aims to address the increasing global demand for biologics, enhancing ProBioGen's ability to support partners from cell line development t
Successfully transformed the organization from a two-country operation focused on development and manufacturing to a fully integrated company with a strong commercial engine bringing us closer to patients in over 120 countries
These initiatives will strengthen the company’s capital base, providing financial flexibility for future
Consequent to this appointment, Sarosh Shetty ceases to be Interim CEO of ICH.
NutrifyGenie AI, a leading AI-driven platform, was integral in designing scientifically differentiated formulations for a multinational client
These three NDAs of Sitagliptin (base) and combination franchise have been approved by the USFDA earlier through the 505(b)(2) route
The biosimilar Ustekinumab has been developed and manufactured by the company
40th DSIR Foundation Day celebration marks 16 more technology transfers from CSIR to MSMEs
Wockhardt plans to launch Miqnaf in the Indian market in coming few months
Prithwish has close to 28 years of experience in a Commercial role
Subscribe To Our Newsletter & Stay Updated
